Watkins Tim
Insider CIK 2065965 · CTNM CMO & Head of Development
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CTNM Contineum Therapeutics, In | M Exercise deriv | 2026-06-30 | 2026-07-01 | 10,833 | — | $0 | 238,334 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2026-06-30 | 2026-07-01 | 10,833 | $16.02 | $173.5K | 8,961 | SEC↗ |
| CTNM Contineum Therapeutics, In | M Exercise | 2026-06-30 | 2026-07-01 | 10,833 | $4.50 | $48.7K | 19,794 | SEC↗ |
| CTNM Contineum Therapeutics, In | M Exercise deriv | 2026-03-02 | 2026-03-02 | 3,611 | — | $0 | 249,167 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2026-03-02 | 2026-03-02 | 3,611 | $15.02 | $54.2K | 0 | SEC↗ |
| CTNM Contineum Therapeutics, In | M Exercise | 2026-03-02 | 2026-03-02 | 3,611 | $4.50 | $16.2K | 3,611 | SEC↗ |
| CTNM Contineum Therapeutics, In | A Award deriv | 2026-01-30 | 2026-01-30 | 160,000 | — | $0 | 160,000 | SEC↗ |
| CTNM Contineum Therapeutics, In | M Exercise deriv | 2026-01-28 | 2026-01-30 | 3,611 | — | $0 | 252,778 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2026-01-28 | 2026-01-30 | 811 | $14.48 | $11.7K | 0 | SEC↗ |
| CTNM Contineum Therapeutics, In | M Exercise | 2026-01-28 | 2026-01-30 | 3,611 | $4.50 | $16.2K | 3,611 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2026-01-28 | 2026-01-30 | 2,800 | $14.09 | $39.5K | 811 | SEC↗ |
| CTNM Contineum Therapeutics, In | M Exercise deriv | 2025-12-29 | 2025-12-30 | 3,611 | — | $0 | 256,389 | SEC↗ |
| CTNM Contineum Therapeutics, In | M Exercise | 2025-12-29 | 2025-12-30 | 3,611 | $4.50 | $16.2K | 3,611 | SEC↗ |
| CTNM Contineum Therapeutics, In | S Sale | 2025-12-29 | 2025-12-30 | 3,611 | $12.06 | $43.5K | 0 | SEC↗ |
| CTNM Contineum Therapeutics, In | A Award deriv | 2025-04-28 | 2025-04-28 | 260,000 | — | $0 | 260,000 | SEC↗ |
| CTNM Contineum Therapeutics, In | A Award deriv | 2025-04-28 | 2025-04-28 | 26,000 | — | $0 | 26,000 | SEC↗ |